Author
Department of Research and Education, Razavi Hospital, Mashhad, IR Iran
Keywords
Open Access Policy: This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. To view a copy of this licence, visit https://creativecommons.org/licenses/by/4.0/
| 1. Henry NL, Hayes DF. Cancer biomarkers. Molecular Oncology. 2012;6(2):140-6. https://doi.org/10.1016/j.molonc.2012.01.010 PMid:22356776 PMCid:PMC5528374 |
||||
| 2. National Cancer Institute.. NCI Dictionary of Cancer Terms. NCI Dictionary of Cancer Terms. USA: National Cancer Institute; 2014. Available from: http://www.cancer.gov/dictionary. | ||||
| 3. Hammond ME, Hayes DF, Dowsett M, Allred DC, Hagerty KL, Badve S, et al. American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer. Arch Pathol Lab Med. 2010;134(6):907-22. https://doi.org/10.5858/134.6.907 PMid:20524868 PMCid:PMC3073033 |
||||
| 4. Wolff AC, Hammond MEH, Hicks DG, Dowsett M, McShane LM, Allison KH, et al. Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update. Archives of Pathology & Laboratory Medicine. 2014;138(2):241-56. https://doi.org/10.5858/arpa.2013-0953-SA PMid:24099077 PMCid:PMC4086638 |
||||
| 5. College of American Pathologists.. Cancer Protocol Templates. 2014. Available from: http://www.cap.org. | ||||
| 6. Bartley AN, Hamilton SR. Select biomarkers for tumors of the gastrointestinal tract: present and future. Arch Pathol Lab Med. 2015;139(4):457-68. https://doi.org/10.5858/arpa.2014-0189-RA PMid:25333834 |
||||
| 7. Bernicker E. Biomarker testing in non-small cell lung cancer: a clinician's perspective. Arch Pathol Lab Med. 2015;139(4):448-50. https://doi.org/10.5858/arpa.2014-0085-ED PMid:25166873 |
||||
| 8. Matynia AP, Szankasi P, Shen W, Kelley TW. Molecular genetic biomarkers in myeloid malignancies. Arch Pathol Lab Med. 2015;139(5):594-601. https://doi.org/10.5858/arpa.2014-0096-RA PMid:25152312 |
||||
| 9. Chastain EC, Duncavage EJ. Clinical Prognostic Biomarkers in Chronic Lymphocytic Leukemia and Diffuse Large B-Cell Lymphoma. Archives of Pathology & Laboratory Medicine. 2015;139(5):602-7. 10. Cagle PT, Olsen RJ, Portier BP, Takei H, Bernard DW. A new everevolving paradigm. Arch Pathol Lab Med. 2015;139(4):446-7. https://doi.org/10.5858/arpa.2014-0629-ED PMid:25822762 |
||||
| 10. Yu PP, Hoffman MA, Hayes DF. Biomarkers and oncology: the path forward to a learning health system. Arch Pathol Lab Med. 2015;139(4):451-6. https://doi.org/10.5858/arpa.2014-0080-ED PMid:25152310 |
||||
| 11. Sholl LM. Biomarkers in lung adenocarcinoma: a decade of progress. Arch Pathol Lab Med. 2015;139(4):469-80. https://doi.org/10.5858/arpa.2014-0128-RA PMid:25255293 |
||||
| 12. Cagle PT, Stein K, Oommen J, Shemon M, Kyle W. Cancer biomarker testing in the everyday practice of pathology. Arch Pathol Lab Med. 2015;139(5):583-4. https://doi.org/10.5858/arpa.2015-0025-ED PMid:25927145 |
||||
| 13. Simpson RW, Berman MA, Foulis PR, Divaris DX, Birdsong GG, Mirza J, et al. Cancer biomarkers: the role of structured data reporting. Arch Pathol Lab Med. 2015;139(5):587-93. https://doi.org/10.5858/arpa.2014-0082-RA PMid:25275812 |
||||
)